Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 19, 2021

SELL
$2.5 - $40.97 $625 - $10,242
-250 Closed
0 $0
Q3 2020

Oct 21, 2020

BUY
$23.7 - $51.1 $5,925 - $12,775
250 New
250 $10,000
Q2 2019

Jul 15, 2019

SELL
$5.43 - $7.19 $54,300 - $71,900
-10,000 Closed
0 $0
Q1 2019

Apr 11, 2019

BUY
$4.76 - $5.8 $47,600 - $58,000
10,000 New
10,000 $0
Q1 2018

Apr 05, 2018

SELL
$5.43 - $7.49 $54,300 - $74,900
-10,000 Closed
0 $0
Q3 2017

Oct 19, 2017

BUY
$6.67 - $8.39 $66,700 - $83,900
10,000
10,000 $2,000

About BiondVax Pharmaceuticals Ltd.


  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.